foxo4 dri senolytic peptide human trials The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI non-toxic injection vit b12 dosage AOD9604:5mg Vial
SKU: 4870359163
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18